文献速递乳房整形与再造

牛源性脱细胞真皮基质在即刻乳房重建中的应用:一项使用SurgiMend的回顾性观察研究

Bovine Acellular Dermal Matrix in Immediate Breast Reconstruction: A Retrospective, Observational Study with SurgiMend.
PubMed 文献 · Plast Reconstr Surg · 2018-01-01

这项回顾性单中心研究分析了111例成年患者(147侧乳房)在乳房切除术后接受一期(83.7%)或二期(16.3%)即刻乳房重建,使用SurgiMend脱细胞真皮基质。中位随访24.3个月后,轻微和严重并发症总发生率分别为25.2%和12.9%,包膜挛缩率2.7%,植入物取出率2.7%。吸烟与严重并发症风险升高相关(p=0.013),术后放疗与包膜挛缩相关(p=0.006),肥胖与植入物取出相关(p=0.006)。

要点

  • SurgiMend用于即刻乳房重建时严重并发症率为12.9%,最常见为血清肿(8.2%)和坏死(6.1%)。
  • 吸烟者发生严重并发症风险更高(p=0.013)。
  • 术后放疗与包膜挛缩相关(p=0.006),肥胖与植入物取出相关(p=0.006)。

核心结论

  • 结果与既往SurgiMend分析一致,支持其在假体乳房重建中的价值。

研究设计与样本

  • 回顾性单中心分析,纳入111例成年患者(147侧乳房),接受一期(83.7%)或二期(16.3%)即刻乳房重建。
  • 中位随访24.3个月。

主要发现

  • 轻微并发症率为25.2%(37/147),严重并发症率为12.9%(19/147)。
  • 最常见的严重并发症为血清肿12例(8.2%)和坏死9例(6.1%),均发生在术后3个月内。
  • 包膜挛缩率为2.7%(4例),植入物取出率为2.7%(4侧乳房)。
  • 单因素分析中,吸烟者严重并发症风险更高(p=0.013),术后放疗与包膜挛缩相关(p=0.006),肥胖与植入物取出相关(p=0.006)。
  • 多因素分析中,肥胖(p<0.05)、术前化疗(p<0.001)和乳房切除重量(p<0.05)与并发症或植入物取出相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Acellular dermal matrices can be combined with implant-based breast reconstruction to help optimize outcomes. SurgiMend PRS is a fetal bovine dermis-derived acellular dermal matrix composed of type I collagen and approximately 30 percent type III collagen, sharing many of the properties of human cadaveric acellular dermal matrix. METHODS: This was a retrospective, single-center analysis of 111 adult patients (147 breasts) undergoing one-stage (83.7 percent) or two-stage (16.3 percent) immediate breast reconstruction after mastectomy. The aims were to characterize the safety profile of SurgiMend and investigate associations between risk factors and complications. RESULTS: The mean age of the patients was 47.9 years and the mean body mass index was 24.7 kg/m. After a median follow-up of 24.3 months, the overall rates of minor and major complications were 25.2 percent (n = 37 of 147) and 12.9 percent (n = 19 of 147), respectively. The most common major complications were seroma [n = 12 (8.2 percent)] and necrosis [n = 9 (6.1 percent)]. All occurred within 3 months after surgery. The rate of capsular contracture was 2.7 percent (n = 4). A total of 2.7 percent of implanted breasts (n = 4) required explantation. In a univariate analysis, smokers had a greater risk of major complications (p = 0.013), and postoperative radiation therapy and obesity were associated with an increased risk of capsular contracture (p = 0.006) and explantation (p = 0.006), respectively. In a multivariate analysis, several factors were associated with complications or explantation, including obesity (p < 0.05), preoperative chemotherapy (p < 0.001), and mastectomy weight (p < 0.05). These associations align with other studies of implant-based reconstruction and do not appear to be specific to this acellular dermal matrix. CONCLUSION: The results are consistent with previous analyses of SurgiMend, and support its value in implant-based breast reconstruction. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Scheflan M, Grinberg-Rashi H, Hod K, et al. Bovine Acellular Dermal Matrix in Immediate Breast Reconstruction: A Retrospective, Observational Study with SurgiMend. Plast Reconstr Surg. 2018. PMID: 29280856. doi:10.1097/PRS.0000000000003982

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。